|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
DK0699687T3
(da)
*
|
1994-08-31 |
2004-04-26 |
Mitsubishi Pharma Corp |
Fremgangsmåde til oprensning af rekombinant humant serumalbumin
|
|
WO1997031947A1
(en)
*
|
1996-02-29 |
1997-09-04 |
Delta Biotechnology Limited |
High purity albumin production process
|
|
US6632648B1
(en)
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
|
EP0947581A4
(en)
*
|
1996-08-08 |
2004-07-28 |
Mitsubishi Pharma Corp |
CULTURAL MEDIUM AND ITS USE.
|
|
IL137649A
(en)
*
|
1998-02-18 |
2004-08-31 |
Genentech Inc |
Method of adsorption chromatography
|
|
US7279001B2
(en)
*
|
1998-11-06 |
2007-10-09 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US6899889B1
(en)
*
|
1998-11-06 |
2005-05-31 |
Neomend, Inc. |
Biocompatible material composition adaptable to diverse therapeutic indications
|
|
US7351249B2
(en)
*
|
1998-11-06 |
2008-04-01 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of suture sites
|
|
US6830756B2
(en)
*
|
1998-11-06 |
2004-12-14 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
|
WO2001085928A1
(en)
*
|
2000-05-10 |
2001-11-15 |
Mitsubishi Pharma Corporation |
Method of preparing virus vector
|
|
US6787636B1
(en)
|
2000-07-14 |
2004-09-07 |
New Century Pharmaceuticals, Inc. |
Modified serum albumin with reduced affinity for nickel and copper
|
|
EP1175931A1
(en)
*
|
2000-07-25 |
2002-01-30 |
Computer Cell Culture Center S.A. |
Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
|
|
DK1399568T3
(da)
|
2001-02-01 |
2006-03-27 |
Hoffmann La Roche |
Fremgangsmåde til fremstilling af rekombinant trypsin
|
|
JP2002265383A
(ja)
*
|
2001-03-14 |
2002-09-18 |
Mitsubishi Pharma Corp |
インターフェロンα注射用液状製剤
|
|
ES2298378T3
(es)
|
2001-06-28 |
2008-05-16 |
Novo Nordisk A/S |
Formulacion estable de glp-1 modificado.
|
|
ITBO20010426A1
(it)
|
2001-07-06 |
2003-01-06 |
Alfa Wassermann Spa |
Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
|
|
KR20030007186A
(ko)
*
|
2001-07-17 |
2003-01-23 |
미쯔이카가쿠 가부시기가이샤 |
광 양이온성 경화가능 수지 조성물 및 그 용도
|
|
US7351800B2
(en)
|
2002-02-28 |
2008-04-01 |
Nipro Corporation |
Stabilized albumin preparations
|
|
SE526227C2
(sv)
|
2002-05-15 |
2005-08-02 |
North China Pharmaceutical Group |
Metod för rening av rekombinant humant serumalbumin
|
|
WO2004048588A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Novo Nordisk A/S |
Process for purifying a fermentation-derived product
|
|
CN1756587A
(zh)
*
|
2003-03-12 |
2006-04-05 |
弗雷泽纽斯卡比德国有限公司 |
重组白蛋白在肝衰竭后透析中的用途
|
|
EP1633391B1
(en)
|
2003-06-03 |
2011-10-19 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
|
KR101308912B1
(ko)
|
2003-06-03 |
2013-09-23 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
|
KR101243648B1
(ko)
|
2003-11-20 |
2013-03-14 |
노보 노르디스크 에이/에스 |
제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
|
|
JP2005245269A
(ja)
*
|
2004-03-03 |
2005-09-15 |
Nipro Corp |
血清アルブミン多量体を含む遺伝子組換え型蛋白質
|
|
ES2347902T3
(es)
*
|
2004-04-23 |
2010-11-22 |
Conjuchem Biotechnologies Inc. Canadian Corporation 4528590 |
Fase solida para uso en un procedimiento para la purificacion de conjugados de albumina.
|
|
US9624260B2
(en)
|
2004-06-07 |
2017-04-18 |
Therapure Biopharma Inc. |
Process for isolation of plasma or serum proteins
|
|
CN100374560C
(zh)
*
|
2004-08-27 |
2008-03-12 |
富岩 |
高效表达人血清白蛋白酵母菌株的构建及发酵纯化工艺
|
|
JP4965446B2
(ja)
|
2004-08-31 |
2012-07-04 |
ノヴォ ノルディスク アー/エス |
ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス(ヒドロキシメチル)アミノメタンの使用
|
|
RU2413530C9
(ru)
|
2004-11-12 |
2021-05-18 |
Ново Нордиск А/С |
Стабильные препараты инсулинотропных пептидов
|
|
CN1854306B
(zh)
*
|
2005-04-29 |
2011-07-27 |
华北制药集团新药研究开发有限责任公司 |
发酵生产重组人血清白蛋白hsa的方法
|
|
IL169230A
(en)
|
2005-06-16 |
2012-03-29 |
Plasan Sasa Agricultural Cooperative Soc Ltd |
Ballistic armor
|
|
WO2007063129A2
(en)
*
|
2005-12-02 |
2007-06-07 |
Novozymes A/S |
Insolation of peptides , polypeptides and proteins
|
|
JP4935242B2
(ja)
*
|
2006-08-24 |
2012-05-23 |
ニプロ株式会社 |
脂肪酸を含有するs−ニトロソタンパク質とその製法
|
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
JP2010515441A
(ja)
*
|
2007-01-15 |
2010-05-13 |
アップフロント・クロマトグラフィ・アクティーゼルスカブ |
原材料からのバイオ燃料およびタンパク質の製造
|
|
DK2370561T3
(da)
|
2008-12-16 |
2019-10-21 |
Emd Millipore Corp |
Omrøringstankreaktor og fremgangsmåde
|
|
SG173469A1
(en)
|
2009-02-20 |
2011-09-29 |
Ventria Bioscience |
Cell culture media containing combinations of proteins
|
|
CN102190722B
(zh)
*
|
2010-03-16 |
2014-03-26 |
上海欣瑞特生物医药技术有限公司 |
一种纯化重组人血白蛋白的方法
|
|
CN102892791B
(zh)
|
2010-05-17 |
2017-05-17 |
Emd密理博公司 |
用于纯化生物分子的刺激响应性聚合物
|
|
CN102532254B
(zh)
*
|
2010-12-24 |
2015-06-24 |
武汉禾元生物科技股份有限公司 |
一种从水稻种子中分离纯化重组人血清白蛋白的方法
|
|
WO2012177792A2
(en)
|
2011-06-24 |
2012-12-27 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of a genetic variation
|
|
US9984198B2
(en)
|
2011-10-06 |
2018-05-29 |
Sequenom, Inc. |
Reducing sequence read count error in assessment of complex genetic variations
|
|
US10196681B2
(en)
|
2011-10-06 |
2019-02-05 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP2764458B1
(en)
|
2011-10-06 |
2021-04-07 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US10424394B2
(en)
|
2011-10-06 |
2019-09-24 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
WO2013052913A2
(en)
|
2011-10-06 |
2013-04-11 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
ES2929923T3
(es)
|
2012-01-20 |
2022-12-02 |
Sequenom Inc |
Procesos de diagnóstico que condicionan las condiciones experimentales
|
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
|
US10497461B2
(en)
|
2012-06-22 |
2019-12-03 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US10482994B2
(en)
|
2012-10-04 |
2019-11-19 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US20130309666A1
(en)
|
2013-01-25 |
2013-11-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP4187543A1
(en)
|
2013-04-03 |
2023-05-31 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
AU2014268377B2
(en)
|
2013-05-24 |
2020-10-08 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
DK3011051T3
(da)
|
2013-06-21 |
2019-04-23 |
Sequenom Inc |
Fremgangsmåde til ikke-invasiv evaluering af genetiske variationer
|
|
US10964409B2
(en)
|
2013-10-04 |
2021-03-30 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
JP6680680B2
(ja)
|
2013-10-07 |
2020-04-15 |
セクエノム, インコーポレイテッド |
染色体変化の非侵襲性評価のための方法およびプロセス
|
|
US11783911B2
(en)
|
2014-07-30 |
2023-10-10 |
Sequenom, Inc |
Methods and processes for non-invasive assessment of genetic variations
|
|
PT3240798T
(pt)
|
2015-01-01 |
2020-05-07 |
Shilpa Medicare Ltd |
Novo método para purificação eficiente de albumina do soro humana
|
|
US11200963B2
(en)
|
2016-07-27 |
2021-12-14 |
Sequenom, Inc. |
Genetic copy number alteration classifications
|
|
CA3207879C
(en)
|
2017-01-24 |
2026-06-16 |
Sequenom, Inc. |
Methods and processes for assessment of genetic variations
|
|
EP3998350B1
(en)
|
2017-03-17 |
2025-05-07 |
Sequenom, Inc. |
Methods and processes for assessment of genetic mosaicism
|
|
BR112020002804A2
(pt)
|
2017-08-24 |
2020-07-28 |
Novo Nordisk A/S |
composição farmacêutica líquida, e, kit
|
|
IL294521A
(en)
|
2020-02-18 |
2022-09-01 |
Novo Nordisk As |
glp-1 compounds and their uses
|
|
US12629445B2
(en)
|
2020-03-20 |
2026-05-19 |
Bard Peripheral Vascular, Inc. |
Reactive hydrogel forming formulations and related methods, including methods of preparation
|
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
|
US12559518B2
(en)
|
2020-12-08 |
2026-02-24 |
Tonghua Anrate Biopharmaceutical Co., Ltd |
Method for purification of recombinant proteins
|
|
WO2022146917A1
(en)
|
2020-12-28 |
2022-07-07 |
Davol Inc. |
Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
|